Natalie Huang, MD, discusses incorporating new and emerging therapies for neovascular age-related macular degeneration and diabetic eye disease into your clinic to alleviate the high treatment burden and other barriers to optimal outcomes that patients experience. Dr. Huang shares insights into how home monitoring systems and AI technologies may be used to benefit patients.
This content was captured during a synchronous in-person and virtual symposium. Polling took place during the symposium.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

























